How will the treatment landscape for CLL change in the next few years?

Published on

At the 20th Congress of the European Hematology Association (EHA), Dr Paolo Ghia, of the Università Vita-Salute San Raffaele, Milan, Italy, explains how new drug combinations may impact the treatment landscape for patients with chronic lymphocytic leukaemia in the next few years.

View more programs featuring

Page last updated on January 26, 2016